ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,780, issued on March 4, was assigned to AKROSWISS AG (Zug, Switzerland).
"Bi-dose nasal spray" was invented by Johannes Malte Frohlich (Zollikon, Switzerland), Matthias Gergely Zadory (Dietikon, Switzerland) and Stefan Pascal Biendl (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "A nasal spray containing an aqueous solution or a fluid with an anxiolytic or anticonvulsant substance, wherein the nasal spray is characterized in that with the nasal spray, two sprays with each an equivalent, defined volume of the aqueous solution or liquid of the active agent, can be intranasally administered to a patient. The nasal spray allows for an...